德尔塔9-甲基卡纳比诺 (THC) 有效地减少化学疗法诱导的恶心和吐在耐标准抗药患者中. 这项研究建议放宽对THC的限制.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 化疗经常导致严重的恶心和吐.
- 标准的抗药对一些患者是无效的.
研究的目的:
- 为了评估delta-9-tetrahydrocannabinol (THC) 作为耐化学治疗诱导的恶心和吐 (CINV) 患者的反吐药的疗效.
主要方法:
- 53名患者在化疗前8-12小时,化疗期间和化疗后24小时接受了THC.
- 患者之前曾经经历过对标准抗药物耐药的CINV.
主要成果:
- 19%的患者没有恶心或吐.
- 53%的恶心和吐至少减少了50%.
- 28%的人没有看到明显的减少.
- 毒性反应通常是轻微的,只有4名患者停止了THC.
结论:
- 对于耐火性CINV,THC显示出显著的抗性质.
- 应该重新考虑目前对THC治疗用途的限制.
- THC提供了一个可行的选择来管理难以治疗的CINV.
更多相关视频
05:56Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
相关概念视频
Prevention of Further Absorption of Poison
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
